FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength

Fri, 02 Mar 2007 02:00 PM EST

... Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that it has been notified by United States Food and Drug Administration("FDA") that its pending application for KADIAN(R) 200mg capsule has received approval. The company expects to launch this new dosage strength in the second quarter of 2007. [click link for full article] ...